Skip to main content
. 2021 Oct 28;139(12):1794–1806. doi: 10.1182/blood.2021011895

Figure 4.

Figure 4

Progression-free survival according to detectable disease status by flow cytometry and NGS. Patients were grouped according to whether MRD was detectable (MRD positive) or undetectable (uMRD; <10−4) in peripheral blood as analyzed by flow cytometry and by response (A) or detectable (MRD positive) or undetectable (uMRD; <10−4) in bone marrow as analyzed by NGS and by response (B). Response was classified as CR or PR.